
via Duke University
Man-made blood vessels developed by researchers at Duke University, Yale University and the tissue engineering company Humacyte appear to be both safe and more durable than commonly used synthetic versions in patients undergoing kidney dialysis, the researchers report.
The findings, published May 12 in The Lancet, resulted from a phase 2 study among 60 patients with kidney failure who required dialysis, which often requires a synthetic graft when the patient’s own blood vessel degrades from frequent needle sticks.
Such grafts, however, are prone to infection, clotting, and other complications. And alternative bioengineered grafts derived from the patient, a donor, or animal tissue have been shown to perform no better than synthetics.
The Duke and Yale research team — along with surgeons in Poland and the United States and scientists at Humacyte, which is developing the bioengineered vessel — tested a human acellular vessel, or HAV, that is manufactured to be available to patients on demand, rather than made-to-order using an individual’s own cells.
“The bioengineered blood vessel represents a critical step in tissue engineering,” said Jeffrey Lawson, M.D., Ph.D., professor of surgery and pathology at Duke and chief medical officer of Humacyte. “Because these vessels contain no living cells, patients have access to off-the-shelf engineered grafts that can be used without any waiting period associated with tailor-made products.”
Lawson and co-author Laura Niklason, M.D., Ph.D., professor of anesthesiology and biomedical engineering at Yale, are principals of Humacyte, Inc., which supported the clinical trial.
To create the vessels, the researchers first isolated vascular cells from human donors and grew them in tissue culture. They then placed the cells on a degradable scaffold shaped like a blood vessel. As the tissue grew, it was bathed in nutrients and stretched to acquire the physical properties of real blood vessels.
“After that process, which takes eight weeks, the scaffold degrades and what we have left is engineered tissue that we have grown from scratch,” Niklason said.
The final step was to wash away the cells with a special solution. The remaining “de-cellularized” tissue retains the structure of the vessel but none of the components that would cause tissue rejection.
One year after implantation, the bioengineered vessels appeared to be both safe and functional, maintaining their mechanical integrity, the researchers report. The patients also showed no sign of rejection.
While there were cases of adverse events such as clotting, the rates of those events were comparable to other dialysis grafts. Notably, the durability of the bioengineered vessels at one year was 89 percent, compared to the approximately 60-percent rate of synthetic grafts reported in previous studies.
Additionally, the researchers noted that after implantation, the bioengineered vessels had been repopulated with the patient’s own cells, so nonliving tissue became living over time.
“The fact that an implanted acellular tube becomes a living human tissue has implications for regenerative medicine in a very profound way,” Lawson said.
Learn more: Bioengineered Blood Vessel Appears Safe for Dialysis Patients
The Latest on: Bioengineered Blood Vessel
[google_news title=”” keyword=”Bioengineered Blood Vessel” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Bioengineered Blood Vessel
- Blood Clots Directoryon June 4, 2023 at 10:44 am
Blood clots happen when substances in the blood clump together as a result of injury to a blood vessel. The substances, called platelets, "plug" the damaged area to prevent blood leakage.
- pressure vesselon June 3, 2023 at 4:59 pm
(Video, embedded below.) The build starts with a large metal plug which screws into the pressure vessel, into which a square recess is machined. For the electrical passthrough, [Eric] selected GX ...
- New method tracking changes in blood vessels could advance brain disease detectionon May 24, 2023 at 5:00 pm
In a new study, Brown-led researchers show that it is possible to track how blood vessels in the brains of mice change over long periods of time. The results begin to give biomedical researchers a ...
- Blood vessel abnormalities in the eye could drive Alzheimer's diseaseon May 22, 2023 at 6:02 am
Blood vessel abnormalities in the eye are a major factor in the progression of Alzheimer's disease, according to research from Cedars-Sinai investigators published in the peer-reviewed journal ...
- Study: Blood vessel damage could be an Alzheimer's driveron May 19, 2023 at 7:16 pm
Blood vessel abnormalities in the eye are a major factor in the progression of Alzheimer's disease, according to research from Cedars-Sinai investigators published in the journal Alzheimer's ...
- A List of 11 Blood Pressure Medicationson May 17, 2023 at 4:59 pm
This reduces the volume of blood that needs to pass through your blood vessels, which lowers your blood pressure. In certain situations, your body makes hormones called catecholamines. These ...
- Humacyte Gets A Lifelineon May 12, 2023 at 11:40 am
The cells proliferate to form a bioengineered blood vessel as the polymer mesh degrades. It is then decellularized using a proprietary combination of solutions, producing a human acellular vessel ...
- Electronic Artificial Blood Vessels Created for New Vascular Treatmentson May 9, 2023 at 5:00 pm
Researchers have developed electronic artificial blood vessels that can continue to work after implantation in the body to help provide novel treatments for vascular diseases as well as other ...
- Self-Sustaining, Bioengineered Blood Vessels Could Replace Damaged Vessels in Patients (2 of 2) (IMAGE)on September 15, 2021 at 3:13 pm
The paper, by R.D Kirkton at Humacyte Inc. in Durham, NC; and colleagues was titled, "Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human ...
via Bing News